ARCHIVES

Cancer Groups Urge FDA To Spell Out Standards For Data Collection In Time-To-Progression Trials.

This article is from The Cancer Letter archive.

Vol. 34 No. 41 | November 7, 2008

Download PDF Visit The Full Archive

Related Articles

Firm Buys Rights To NKT Cells From Beth Israel Deaconess.

July 28, 2000

Studies Test New Agents Offering Relief From Treatment-Related Side Effects

July 30, 2004

FDA Seeks Consumers For Advisory Committees.

November 23, 2001

FCRF Recompetition Intriguing, Involved Various Possibility

May 9, 1986

Does a B from USPSTF Guarantee Coverage? Lung Screening will Define Medicare Stance

March 21, 2014

NCI Lists Projected Grant Paylines

February 16, 1996